Homeland Security Department Clarifies Origin of Biomedix IV Product
May 23, 2025
May 23, 2025
WASHINGTON, May 23 (TNSFR) -- The U.S. Department of Homeland Security Customs and Border Protection (CBP), under the Department of Homeland Security, has issued a final determination concerning the country of origin for the Biomedix Selec-3 Multiple Drop Intravenous Product.
This ruling, crucial for U.S. Government procurement purposes under the Trade Agreements Act of 1979, clarifies where the medical device is considered to originate based on its manufacturing process and compon . . .
This ruling, crucial for U.S. Government procurement purposes under the Trade Agreements Act of 1979, clarifies where the medical device is considered to originate based on its manufacturing process and compon . . .